ITRI

Itron reported Q3 2026 revenue of $599.33 million, up 3% year-over-year and beating consensus estimates by 0.48%. The company delivered EPS of $1.94, significantly outperforming the consensus estimate of $1.57 by 23.57%.

However, several key revenue segments missed analyst expectations, including Resiliency Solutions and Service revenues. The stock carries a Zacks Rank #4 (Sell) rating.

Itron reported Q3 2026 earnings of $1.94 per share, beating consensus estimates of $1.57, with revenues of $599.33 million slightly exceeding expectations. Despite the earnings beat, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends.

The stock has underperformed the S&P 500 by 17.6% year-to-date. Ametek, a peer in the Electronics - Testing Equipment industry, is expected to report results on November 3.

Itron (ITRI) closed at $82.14, down 1.08% from the prior day and underperforming the S&P 500. The energy and water meter company has declined 8.18% over the past month.

The company is scheduled to report earnings on October 27, 2026, with projected EPS of $1.57 (up 1.95% YoY) and revenue of $596.45 million (up 2.55% YoY). For the full fiscal year, earnings are expected to decline 10.1% while revenue grows 0.87%. Itron holds a Zacks Rank #2 (Buy) with a Forward P/E of 12.95, trading at a discount to its industry average.

Itron (ITRI) closed at $86.62, up 1.23% on the day, outperforming the broader market. However, the stock has declined 6.88% over the past month.

The company is expected to report Q3 2026 earnings on October 27 with an EPS of $1.57 (+1.95% YoY) and revenue of $596.45 million (+2.55% YoY). Full-year estimates project $6.41 EPS and $2.39 billion revenue, representing a -10.1% and +0.87% change respectively. Itron holds a Zacks Rank #2 (Buy) with a Forward P/E of 13.35, trading at a discount to its industry average of 24.37.

Itron (ITRI) closed at $87.79, up 1.48% on the day, but down 10.82% over the past month. The energy and water meter company has a Zacks Rank #2 (Buy) rating with projected quarterly EPS growth of 1.95% and revenue growth of 2.55%. Trading at a Forward P/E of 13.5, well below the industry average of 24.05, the stock appears undervalued relative to peers.

Itron (ITRI) is identified as a compelling value investment opportunity, holding a Zacks Rank #2 (Buy) rating and an A grade for Value. The company's valuation metrics—including a Forward P/E of 19.59 (below industry average of 24.52), P/B ratio of 3.37 (versus industry average of 4.33), and P/CF ratio of 16.89 (compared to industry average of 26.66)—suggest the stock is undervalued relative to its earnings outlook.